Antimicrobial stewardship lessons: Know when to say no to vancomycin

Clinical Infectious Diseases

Volumn 56, Issue 4, 2013, Pages 616-617

  Dos Santos, Rodrigo Pires ^a   Deutschendorf, Caroline ^a   Nagel, Fabiano ^a   Konkewicz, Loriane ^a   Lisboa, Thiago ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC THERAPY; DRUG USE; HUMAN; LETTER; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VENTILATOR ASSOCIATED PNEUMONIA;

BACTERIAL TYPING TECHNIQUES; GENTIAN VIOLET; HUMANS; PHENAZINES; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 84873054845     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis904     Document Type: Letter

References (5)

1. O'Horo JC, Thompson D, Safdar N. Is the Gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis. Clin Infect Dis 2012; 55:551-61.
2. Rello J, Ulldemolins M, Lisboa T, et al. Determinants of prescription and choice of empirical therapy for hospital acquired and ventilator-associated pneumonia. Eur Respir J 2011; 37:1332-9.
3. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31(suppl 4):S131-8.
4. Clark NM, Hershberger E, Zervosc MJ, Lynch JP 3rd. Antimicrobial resistance among gram-positive organisms in the intensive care unit. Curr Opin Crit Care 2003; 9: 403-12.
5. CD+s campaign to prevent antimicrobial resistance in health-care settings. MMWR Morb Mortal Wkly Rep 2002; 51: 343.